PBM Pharmaceuticals
HomeAbout UsProductsNews & MediaHealthcare Professionals


Wednesday, August 29, 2007
European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day

Women Who Take DHA Have Healthier Pregnancies, Fewer Premature Births

GORDONSVILLE, VA-More than 50 nutritional experts from a European Union (EU) committee now recommend pregnant and nursing women supplement their diets on a daily basis with a large amount of DHA, an essential omega-3 fatty acid. Clinically proven in numerous studies to offer a growing array of health benefits, nutritional supplementation of DHA is now being associated with healthier pregnancies.

Just last year, the makers of the prescription supplement Animi-3® noted a study by Dr. Joseph Hibbeln, NIH, which determined DHA supplementation by pregnant women has a discernible positive effect on the mental and social development of their children.*

Likewise, this new European study examined the role of DHA in women's health to improve pregnancy dietary guidelines. The researchers also determined that DHA promotes good health in women and their babies:**
  • Women who include DHA in their diets have babies with healthier birth weights.
  • Women who include DHA in their diets have fewer premature births.
  • DHA intake is directly linked with improving infant mental and visual development well beyond birth.

"This commission's findings confirm that Western diets are often deficient in DHA, especially in the United States," said PBM Pharmaceuticals President Jack Schramm, who specially formulated Animi-3 to address nutritional deficiencies. "In addition to DHA, it is well known that mothers need folic acid for a healthy pregnancy."Doctors are now using PBM's Animi-3 to precisely deliver DHA-dominant omega-3, folic acid, and vitamins B6 and B12 to expectant and nursing mothers, as well as new mothers with postpartum depression. Each capsule of Animi-3 contains 500 mg of omega-3 acids, including 350 mg of DHA. The omega-3 in Animi-3 is all natural, purified to eliminate any contaminants such as heavy metals or PCBs, and comes from a source that has earned USP verification.

For more information on Animi-3, www.animi-3.com.

Source: http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=2600

*Hibbeln, Joseph, NIH, As reported in The Economist, January 19, 2006.
*Koletzko B, Irene C, Thomas BJ for the Perinatal Lipid Intake Working Group (2007). Dietary Fat Intakes For Pregnant And Lactating Women. Abstract presented at the International Congress of Paediatrics, Athens, 29 August 2007.

###

Contact: Joe Shields, Director of Public Relations, (800) 959-2066 ext. 131

                                                                                       
 Animi-3, Donnatal, and Donnatal Extentabs
 ©2005 PBM Pharmaceuticals, PBM Products. All Rights Reserved.